NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Chrysalyne D. Schmults, Rachel Blitzblau, Sumaira Z. Aasi, Murad Alam, James Andersen, Brian C. Baumann, Jeremy S. Bordeaux, Pei-Ling Chen, Robert Chin, Carlo M. Contreras, Dominick J. DiMaio, Jessica M. Donigan, Jeffrey M. Farma, Karthik Ghosh, Roy C. Grekin, Kelly L. Harms, Alan L. Ho, Ashley M. Holder, John N. Lukens, Theresa Medina, Kishwer S. Nehal, Paul Nghiem, Soohyung Park, Tejesh Patel, Igor Puzanov, Jeffrey Scott, Aleksandar Sekulić, Ashok R. Shaha, Divya Srivastava, William G. Stebbins, Valencia D. Thomas, Yaohui Xu, Beth McCullough, Mary A. Dwyer, Mai Q. Nguyen
Abstract
The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.